在固体癌症免疫治疗中通过等离子体对人类Fas联体 (CD95L) 的进化调节
Brice E N Wamba1,2, Tanmoy Mondal1,2, Francis Freenor V1,2
1Laboratory of Novel Biologics, University of California Davis, Davis, CA, USA.
Nature communications
|July 2, 2025
概括
人类的癌症发病率比灵长类更高,原因是Fas Ligand (FasL) 蛋白质的变化. 这种变化使人体FasL易受瘤中的等离子素的影响,阻碍T细胞杀死癌症. 抑制等离子素可能会改善癌症免疫疗法.
科学领域:
- 进化生物学是进化的生物学.
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 人类与非人类灵长类有很高的基因组相似性,但癌症发病率更高.
- 联体 (FasL) 对于免疫平衡和细胞死亡调节至关重要.
- T淋巴细胞和CAR-T细胞利用FasL杀死瘤细胞,这是免疫治疗的一个关键方面.
研究的目的:
- 研究人类和灵长类动物之间不同癌症易感性的进化基础.
- 了解人类特异性FasL改变对癌细胞死亡途径的影响.
- 探索针对等离子体的治疗策略,以增强T细胞介导的抗瘤免疫力.
主要方法:
- 人类和灵长类动物FasL的比较基因组分析.
- 生物化学测试以评估FasL通过等离子体的裂变.
- 在体外研究使用卵巢瘤模型和T淋巴细胞.
- 在等离子体抑制后对T细胞中介细胞毒性的评估.
主要成果:
- 在FasL中,人类特有的Pro153-Ser153替代增加了它对等离子体裂变的敏感性.
- 瘤中的高等离子素水平会损害T淋巴细胞的FasL介导死亡信号.
- 向等离子体恢复了FasL-依赖的T细胞杀死瘤细胞的作用.
- 血抑制增强了T细胞对免疫检查点抗体的反应.
结论:
- 在FasL的进化变化有助于人类的癌症易感性.
- 与瘤相关的等离子素干扰关键的FasL介导的抗瘤免疫反应.
- 向等离子体是一种有前途的策略,可以提高对固体瘤的基于T细胞的免疫疗法的疗效.
更多相关视频
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K


